| Profile | GDS5420 / 240913_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 488.37 | 67 |
| GSM1296119 | B_lesional_pre-dose | 338.95 | 61 |
| GSM1296076 | C_lesional_pre-dose | 147.97 | 49 |
| GSM1296092 | D_lesional_pre-dose | 113.79 | 46 |
| GSM1296103 | E_lesional_pre-dose | 496.13 | 67 |
| GSM1296078 | F_lesional_pre-dose | 157.53 | 50 |
| GSM1296107 | G_lesional_pre-dose | 307.53 | 59 |
| GSM1296109 | H_lesional_pre-dose | 263.36 | 56 |
| GSM1296080 | I_lesional_pre-dose | 310.67 | 60 |
| GSM1296090 | J_lesional_pre-dose | 123.93 | 46 |
| GSM1296074 | K_lesional_pre-dose | 139.7 | 49 |
| GSM1296111 | L_lesional_pre-dose | 359.69 | 62 |
| GSM1296099 | M_lesional_pre-dose | 262.06 | 56 |
| GSM1296086 | O_lesional_pre-dose | 135.38 | 48 |
| GSM1296117 | P_lesional_pre-dose | 285.71 | 58 |
| GSM1296113 | Q_lesional_pre-dose | 352.47 | 61 |
| GSM1296096 | R_lesional_pre-dose | 241.5 | 56 |
| GSM1296105 | S_lesional_pre-dose | 395.5 | 63 |
| GSM1296098 | T_lesional_pre-dose | 765.9 | 75 |
| GSM1296101 | U_lesional_pre-dose | 377.22 | 62 |
| GSM1296121 | V_lesional_pre-dose | 386.81 | 63 |
| GSM1296088 | W_lesional_pre-dose | 358.85 | 62 |
| GSM1296082 | X_lesional_pre-dose | 125.48 | 47 |
| GSM1296115 | Y_lesional_pre-dose | 350.22 | 61 |
| GSM1296084 | Z_lesional_pre-dose | 301.97 | 59 |
| GSM1296072 | B_lesional_day8 | 468.94 | 66 |
| GSM1296069 | L_lesional_day8 | 255.81 | 55 |
| GSM1296071 | P_lesional_day8 | 256.9 | 55 |
| GSM1296070 | Y_lesional_day8 | 375.33 | 62 |
| GSM1296073 | V_lesional_day8 | 206.9 | 53 |
| GSM1296034 | A_lesional_day15 | 660.19 | 72 |
| GSM1296041 | G_lesional_day15 | 359.45 | 62 |
| GSM1296035 | R_lesional_day15 | 180.78 | 51 |
| GSM1296038 | U_lesional_day15 | 320.63 | 60 |
| GSM1296047 | B_lesional_day15 | 472.24 | 66 |
| GSM1296039 | E_lesional_day15 | 256.66 | 57 |
| GSM1296042 | H_lesional_day15 | 320.42 | 60 |
| GSM1296043 | L_lesional_day15 | 307.53 | 58 |
| GSM1296037 | M_lesional_day15 | 283.27 | 58 |
| GSM1296046 | P_lesional_day15 | 507.87 | 67 |
| GSM1296044 | Q_lesional_day15 | 524.44 | 68 |
| GSM1296045 | Y_lesional_day15 | 369.47 | 62 |
| GSM1296025 | C_lesional_day15 | 299.6 | 59 |
| GSM1296033 | D_lesional_day15 | 125.72 | 45 |
| GSM1296027 | I_lesional_day15 | 138.86 | 48 |
| GSM1296032 | J_lesional_day15 | 201.97 | 52 |
| GSM1296024 | K_lesional_day15 | 342.58 | 62 |
| GSM1296031 | W_lesional_day15 | 352.54 | 61 |
| GSM1296028 | X_lesional_day15 | 258.49 | 57 |
| GSM1296029 | Z_lesional_day15 | 142.41 | 47 |
| GSM1296026 | F_lesional_day15 | 142.17 | 48 |
| GSM1296030 | O_lesional_day15 | 88.53 | 42 |
| GSM1296040 | S_lesional_day15 | 588.35 | 70 |
| GSM1296036 | T_lesional_day15 | 755.64 | 74 |
| GSM1296048 | V_lesional_day15 | 219.32 | 54 |
| GSM1296059 | A_lesional_day43 | 168.41 | 50 |
| GSM1296066 | G_lesional_day43 | 249.25 | 55 |
| GSM1296060 | R_lesional_day43 | 249.31 | 56 |
| GSM1296063 | U_lesional_day43 | 272.3 | 57 |
| GSM1296064 | E_lesional_day43 | 319.72 | 61 |
| GSM1296067 | H_lesional_day43 | 356.86 | 61 |
| GSM1296062 | M_lesional_day43 | 333.57 | 60 |
| GSM1296068 | Q_lesional_day43 | 486.97 | 67 |
| GSM1296050 | C_lesional_day43 | 240.37 | 56 |
| GSM1296057 | D_lesional_day43 | 231.68 | 55 |
| GSM1296052 | I_lesional_day43 | 160.06 | 50 |
| GSM1296054 | J_lesional_day43 | 410.57 | 64 |
| GSM1296049 | K_lesional_day43 | 256.31 | 57 |
| GSM1296055 | W_lesional_day43 | 284.97 | 58 |
| GSM1296053 | X_lesional_day43 | 237.01 | 55 |
| GSM1296058 | Z_lesional_day43 | 162.17 | 50 |
| GSM1296051 | F_lesional_day43 | 121.91 | 45 |
| GSM1296056 | O_lesional_day43 | 152.33 | 49 |
| GSM1296065 | S_lesional_day43 | 392.46 | 63 |
| GSM1296061 | T_lesional_day43 | 684.07 | 72 |
| GSM1296095 | A_non-lesional_pre-dose | 331.61 | 61 |
| GSM1296120 | B_non-lesional_pre-dose | 388.62 | 63 |
| GSM1296077 | C_non-lesional_pre-dose | 303.6 | 60 |
| GSM1296093 | D_non-lesional_pre-dose | 188.31 | 50 |
| GSM1296104 | E_non-lesional_pre-dose | 235.38 | 55 |
| GSM1296079 | F_non-lesional_pre-dose | 157.73 | 49 |
| GSM1296108 | G_non-lesional_pre-dose | 370.28 | 62 |
| GSM1296110 | H_non-lesional_pre-dose | 450.1 | 65 |
| GSM1296081 | I_non-lesional_pre-dose | 249.23 | 57 |
| GSM1296091 | J_non-lesional_pre-dose | 169.94 | 51 |
| GSM1296075 | K_non-lesional_pre-dose | 130.09 | 47 |
| GSM1296112 | L_non-lesional_pre-dose | 307.03 | 58 |
| GSM1296100 | M_non-lesional_pre-dose | 468.19 | 66 |
| GSM1296087 | O_non-lesional_pre-dose | 91.22 | 42 |
| GSM1296118 | P_non-lesional_pre-dose | 339.48 | 60 |
| GSM1296114 | Q_non-lesional_pre-dose | 515.08 | 68 |
| GSM1296097 | R_non-lesional_pre-dose | 267.47 | 57 |
| GSM1296106 | S_non-lesional_pre-dose | 575.57 | 70 |
| GSM1296102 | U_non-lesional_pre-dose | 428.5 | 64 |
| GSM1296122 | V_non-lesional_pre-dose | 190.81 | 50 |
| GSM1296089 | W_non-lesional_pre-dose | 625.12 | 71 |
| GSM1296083 | X_non-lesional_pre-dose | 224.79 | 54 |
| GSM1296116 | Y_non-lesional_pre-dose | 387.88 | 63 |
| GSM1296085 | Z_non-lesional_pre-dose | 178.66 | 51 |